Sapio Group has signed an agreement to acquire New Medical Concept, the holding company of the EXPERF Group, from the French Bastide Group. EXPERF is a company specialized in home infusion and home nutrition services.
The transaction enables Sapio to position itself in France as one of the leading players in home infusion therapy and to strengthen its leadership in home nutrition. These are two essential services for the management of chronic and fragile patients, allowing medicines and nutrients to be administered directly at home, improving quality of life and reducing the need for hospitalization, while ensuring continuity of care between hospital and home.
This acquisition represents a key step in Sapio’s strategic plan, whose objective is sustainable growth in Europe and consolidation in the healthcare sector, which offers strong development prospects.
With its extensive and well-established network of 28 agencies and revenue of more than €42 million, EXPERF represents a highly valuable asset, perfectly complementary to the activities that Sapio — whose revenue has exceeded the €1 billion threshold — already carries out in the country. This development makes the company an important accelerator for Sapio’s consolidation and growth strategy in France, contributing to its leading role in the sector and strengthening its proximity to patients.
“We are extremely pleased to have signed the agreement for the acquisition of EXPERF,” said Mario Paterlini, CEO of Sapio Group. “This acquisition represents another important milestone in our strategy, which aims to ensure sustainable growth in Europe, particularly in the healthcare sector, which is marked by strong dynamism. Thanks to its well-established presence across France, EXPERF will act as an accelerator for our consolidation and expansion strategy in the country.”
Completion of the transaction is subject to customary closing conditions, including information and consultation processes with employee representative bodies.
Sapio Group was advised by Goodwin Procter LLP as legal counsel and by Eight Advisory as financial and tax advisor. Marsh supported the insurance due diligence process.